Toxicity and Efficacy of Local Ablative, Image-guided Radiotherapy in Gallium-68 Prostate-specific Membrane Antigen Targeted Positron Emission Tomography-staged, Castration-sensitive Oligometastatic Prostate Cancer: The OLI-P Phase 2 Clinical Trial

COMMENTED

Genitourinary CancerRadio-Oncology

Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial

★ 2 Recommended by Prof. Dr Stephan Bodis, Faculty Member

★ 1 Recommended and commented by Prof. Dr Richard Cathomas, Faculty Member

doi: 10.1001/jamaoncol.2020.0147.

Genitourinary Cancer

Sensitivity, Specificity, and Predictors of Positive ⁶⁸Ga–Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis

Eur Urol.

Perera M, Papa N, Christidis D, Wetherell D, Hofman MS, Murphy DG, Bolton D, Lawrentschuk N

doi: 10.1016/j.eururo.2016.06.021.

Breast Cancer

Recent Developments in Metastatic Breast Cancer

healthbook TIMES Oncology Hematology

Genitourinary Cancer

Prostate-specific Membrane Antigen Positron Emission Tomography-detected Oligorecurrent Prostate Cancer Treated with Metastases-directed Radiotherapy: Role of Addition and Duration of Androgen Deprivation

Eur Urol Focus.

Kroeze SGC, Henkenberens C, Schmidt-Hegemann NS, Vogel MME, Kirste S, Becker J, Burger IA, Derlin T, Bartenstein P, Eiber M, Mix M, la Fougère C, Christiansen H, Belka C, Combs SE, Grosu AL, Müller AC, Guckenberger M

doi: 10.1016/j.euf.2019.08.012.

Genitourinary Cancer

Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer

BJU Int.

van Leeuwen PJ, Emmett L, Ho B, Delprado W, Ting F, Nguyen Q, Stricker PD

doi: 10.1111/bju.13540.

Genitourinary CancerRadio-Oncology

Daily versus weekly prostate cancer image-guided radiotherapy: Phase 3 multicenter randomized trial

Int J Radiat Oncol Biol Phys.

de Crevoisier R, Bayar MA, Pommier P, Muracciole X, Pêne F, Dudouet P, Latorzeff I, Beckendorf V, Bachaud JM, Laplanche A, Supiot S, Chauvet B, Nguyen TD, Bossi A, Créhange G, Lagrange JL

doi: 10.1016/j.ijrobp.

COMMENTED

Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multi-centre study

★ 3 Recommended by Prof. Dr Stephan Bodis, Faculty Member

★ 2 Recommended and commented by Prof. Dr Richard Cathomas, Faculty Member

doi: 10.1016/S0140-6736(20)30314-7.

COMMENTED

Genitourinary CancerRadio-Oncology

Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multi-centre study

★ 3 Recommended by Prof. Dr Stephan Bodis, Faculty Member

★ 2 Recommended and commented by Prof. Dr Richard Cathomas, Faculty Member

doi: 10.1016/S0140-6736(20)30314-7.

RECOMMENDED

Genitourinary CancerRadio-Oncology

Stereotactic Abative Body Radiotherapy (SABR) for Oligometastatic Prostate Cancer: A Prospective Clinical Trial

Eur Urol.

Siva S, Bressel M, Murphy DG, Shaw M, Chander S, Violet J, Tai KH, Udovicich C, Lim A, Selbie L, Hofman MS, Kron T, Moon D, Goad J, Lawrentschuk N, Foroudi F

doi: 10.1016/j.eururo.2018.06.004.

Related content

Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial

Sensitivity, Specificity, and Predictors of Positive 68Ga–Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis

Recent Developments in Metastatic Breast Cancer

Prostate-specific Membrane Antigen Positron Emission Tomography-detected Oligorecurrent Prostate Cancer Treated with Metastases-directed Radiotherapy: Role of Addition and Duration of Androgen Deprivation

Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer

Daily versus weekly prostate cancer image-guided radiotherapy: Phase 3 multicenter randomized trial

Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multi-centre study

Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multi-centre study

Stereotactic Abative Body Radiotherapy (SABR) for Oligometastatic Prostate Cancer: A Prospective Clinical Trial

Sensitivity, Specificity, and Predictors of Positive ⁶⁸Ga–Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis